… It occurs in isolation (primary antiphospholipid syndrome) in more than 50% of … antiphospholipid
syndrome.3 An acute variant of the syndrome—catastrophic antiphospholipid syndrome…

… The anti-phospholipid syndrome (APS) is a systemic autoimmune disorder characterized
by recurrent thrombosis and/or obstetrical morbidity along with persistent anti-phospholipid …

… These include the laboratory assays involved in antiphospholipid … , management of
recurrent thrombosis, individuals with isolated aPL, and catastrophic antiphospholipid syndrome. …

The objective was to develop evidence-based recommendations for the management of
antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature …

Antiphospholipid syndrome, also known as ‘Hughes Syndrome’, is an autoimmune disease
characterised by a set of clinical manifestations, almost all of which are direct or indirect …

… landscape of antiphospholipid syndrome diagnosis, pathogenesis, and management with
a … more about the clinical care and research of patients with antiphospholipid syndrome. …

… therapeutics will alter diagnosis and management. Antiphospholipid syndrome (APS) is …
persistent positivity of autoantibodies known as antiphospholipid antibodies (aPL) (Miyakis …

… Antiphospholipid syndrome (APS) is characterized by recurrent venous or arterial
thromboses, fetal losses and thrombocytopenia in the presence of antiphospholipid antibodies, …

Antiphospholipid syndrome (APS), is an acquired autoimmune disorder characterised by
thrombosis, pregnancy morbidity, and the presence of antiphospholipid … its management should …

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by …
morbidity in the presence of persistent antiphospholipid (aPL) autoantibodies. Anticoagulation …